|Articles|February 1, 2006

Pharmacy Times

  • Volume 0
  • 0

Ampicillin and Sulbactam for Injection

American Pharmaceutical Partners(Schaumburg, Ill) recently received FDAapproval for its abbreviated new drugapplication for Ampicillin and Sulbactamfor Injection. The product is the genericequivalent of Pfizer Inc's Unasyn. Ampicillinand Sulbactam is an injectableantibacterial combination consisting ofthe semisynthetic antibiotic ampicillinsodium and the beta-lactamase inhibitorsulbactam sodium. The product is indicatedfor the treatment of several skinand skin structure, intra-abdominal, andgynecologic infections due to susceptiblestrains of microorganisms. Administeredintravenously or intramuscularly, Ampicillinand Sulbactam for Injection isavailable in 1.5-and 3-g single-dose vials.The product is preservative-free, andeach vial will include a bar code andlatex-free vial stopper. For more information,visit www.appdrugs.com.

Articles in this issue

over 19 years ago

can you READ these Rxs?

over 19 years ago

Compounding HOTLINE

over 19 years ago

A Look at Diabetic Retinopathy

over 19 years ago

The Graying of HIV

over 19 years ago

AutoCarousel

over 19 years ago

Lexi-Comp Knowledge Solution

over 19 years ago

Refill TeleManager

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME